Baricitinib after clot removal for stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether the drug baricitinib, given after a mechanical clot-removal procedure, helps improve recovery in people who had a stroke from a large clot in the front of the brain. The drug may reduce inflammation and protect brain tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You had a stroke from a large clot in the front part of the brain, confirmed by imaging, and you can be enrolled within 24 hours of the stroke starting.
- You had a mechanical thrombectomy (clot removal) that was successful (blood flow restored).
- You must not have a bleeding condition or be on blood thinners that increase bleeding risk.
- You cannot be pregnant, breastfeeding, or have a history of hepatitis or tuberculosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if adding an interleukin-6 receptor inhibitor (a drug that reduces inflammation) to standard emergency clot removal can improve recovery for people with a severe stroke affecting the back part of the brain (posterior circulation). It is for patients who need urgent treatment within 24 hours of symptom onset.
This study tests whether a medication called baricitinib can help protect the lungs in people who have had a sudden bleed around the brain. Baricitinib works by calming inflammation, which might reduce lung injury after the bleeding.
This trial tests if baricitinib, an anti-inflammatory drug, can help people with bleeding in the brain from a head injury. It is for adults with moderate to severe traumatic brain injury who are not immediately having surgery.
This trial tests a pill called baricitinib to see if it helps people recover from lung injury after a brain bleed. It is for patients who need a breathing machine due to ARDS that started within a week of the bleed.
This trial tests if baricitinib, a medication for rheumatoid arthritis, can improve blood clotting issues that some patients with active RA face. It is for adults whose RA is not well-controlled by standard treatments.
This trial tests if adding a blood thinner called tirofiban after successful clot removal can improve recovery in people with severe stroke. It is for patients who had a large blockage and are treated within 24 hours of symptoms starting.
Hear when a new Acute Ichemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.